Generics - Mallinckrodt

Filter

Current filters:

Mallinckrodt

Popular Filters

US FDA accepts Pennsaid 2% NDA for review

22-08-2013

The US Food and Drug Administration has accepted for filing US drugmaker Mallinckrodt's (NYSE: MNK) New…

Anti-Arthritics/RheumaticsGenericsMallinckrodtNorth AmericaNuvo ResearchPennsaidPharmaceuticalRegulation

Nuvo Research in patent settlement over Pennsaid

29-01-2013

Canada's Nuvo Research (TSX: NRI) says it has entered into a settlement agreement with Apotex Inc and…

Anti-Arthritics/RheumaticsApotexGenericsMallinckrodtNorth AmericaNuvo ResearchPatentsPennsaid

Mallinckrodt to acquire CNS Thera for $100 million; Mediq to sell out for 775 million euros

25-09-2012

Mallinckrodt, the soon to be spun-out pharmaceuticals business of Ireland-based Covidien (NYSE: COV),…

CNS TherapeuticsCovidienGenericsMallinckrodtMediqMergers & AcquisitionsPharmaceutical

Back to top